Background: The introduction and refinement of coronary-artery stenting dra
matically changed the practice of percutaneous coronary revascularization i
n the mid-1990s. We analyzed one-year follow-up data for all percutaneous c
oronary interventions performed in a large, unselected population in Canada
to determine whether the use of coronary stenting has been associated with
improved outcomes.
Methods: Prospectively collected data on all percutaneous coronary interven
tions performed on residents of British Columbia, Canada, between April 199
4 and June 1997 were linked to province-wide health care data bases to prov
ide the date of the following end points: subsequent target-vessel revascul
arization, myocardial infarction, and death. Base-line characteristics and
procedural variables were identified and Kaplan-Meier survival curves were
generated for 9594 procedures divided into seven groups, one for each seque
ntial half-year period.
Results: The overall burden of coexisting illnesses remained stable through
out the study period. A large increase in the rate of coronary stenting (fr
om 14.2 percent in the period from April to June 1994 to 58.7 percent in th
e period from January to June 1997) was associated with a significant reduc
tion in the rate of adverse cardiac events at one year (from 28.8 percent t
o 22.8 percent; adjusted relative risk, 0.79; 95 percent confidence interva
l, 0.69 to 0.90; P<0.001). This reduction in adverse events was exclusively
due to a large reduction in subsequent target-vessel revascularization (fr
om 24.4 percent to 17.0 percent; adjusted relative risk, 0.72; 95 percent c
onfidence interval, 0.62 to 0.83; P<0.001) without significant changes in t
he overall rates of myocardial infarction (5.4 percent, P=0.28) or death (3
.9 percent, P=0.65).
Conclusions: The need for target-vessel revascularization during one year o
f follow-up after percutaneous coronary intervention decreased during the m
id-1990s. The reduction was coincident with the introduction and subsequent
widespread use of coronary stenting. (N Engl J Med 1999;341:1957-65.) (C)1
999, Massachusetts Medical Society.